EDGAR Filing Documents for 0001410578-24-000297

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:

SEC Accession No. 0001410578-24-000297

Filing Date

2024-03-26

Accepted

2024-03-25 17:37:56

Documents

Period of Report

2023-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	10-K	mrkr-20231231x10k.htm iXBRL	10-K	2043297
2	EX-4.0	mrkr-20231231xex4d0.htm	EX-4.0	5686
3	EX-4.1	mrkr-20231231xex4d1.htm	EX-4.1	21213
4	EX-10.8	mrkr-20231231xex10d8.htm	EX-10.8	175735
5	EX-10.9	mrkr-20231231xex10d9.htm	EX-10.9	122502
6	EX-21.1	mrkr-20231231xex21d1.htm	EX-21.1	1845
7	EX-23.1	mrkr-20231231xex23d1.htm	EX-23.1	2421
8	EX-31.1	mrkr-20231231xex31d1.htm	EX-31.1	11935
9	EX-31.2	mrkr-20231231xex31d2.htm	EX-31.2	14279
10	EX-32.1	mrkr-20231231xex32d1.htm	EX-32.1	8364
11	EX-32.2	mrkr-20231231xex32d2.htm	EX-32.2	8461
12	EX-97	mrkr-20231231xex97.htm	EX-97	42389
13	GRAPHIC	mrkr-20231231x10k001.jpg	GRAPHIC	15804
14	GRAPHIC	mrkr-20231231x10k002.jpg	GRAPHIC	46939
15	GRAPHIC	mrkr-20231231x10k003.jpg	GRAPHIC	34734
16	GRAPHIC	mrkr-20231231x10k004.jpg	GRAPHIC	34708
17	GRAPHIC	mrkr-20231231x10k005.jpg	GRAPHIC	37173
18	GRAPHIC	mrkr-20231231x10k006.jpg	GRAPHIC	74658
19	GRAPHIC	mrkr-20231231x10k007.jpg	GRAPHIC	101808
20	GRAPHIC	mrkr-20231231xex4d0001.jpg	GRAPHIC	444435
21	GRAPHIC	mrkr-20231231xex4d0002.jpg	GRAPHIC	88034
	Complete submission text file	0001410578-24-000297.txt		9852287

Data Files

Seq	Description	Document	Type	Size
22	EX-101.SCH	mrkr-20231231.xsd	EX-101.SCH	52742
23	EX-101.CAL	mrkr-20231231_cal.xml	EX-101.CAL	54491
24	EX-101.DEF	mrkr-20231231_def.xml	EX-101.DEF	219363
25	EX-101.LAB	mrkr-20231231_lab.xml	EX-101.LAB	448427
26	EX-101.PRE	mrkr-20231231_pre.xml	EX-101.PRE	369893
96	EXTRACTED XBRL INSTANCE DOCUMENT	mrkr-20231231x10k_htm.xml	XML	1103520

Mailing Address 4551 KENNEDY COMMERCE DR. HOUSTON TX 77032

Business Address 4551 KENNEDY COMMERCE DR. HOUSTON TX 77032 (713) 400-6400

Marker Therapeutics, Inc. (Filer) CIK: 0001094038 (see all company filings)